☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
nsclc
Blueprint Medicines to Acquire Lengo for ~$250M
November 30, 2021
PharmaShots Interview: Dr. Trevor Feinstein and BeyondSpring's Dr. Lan Huang Shares Insight on the Data of Plinabulin + Docetaxel...
November 8, 2021
Roche Entered into a Clinical Trial Supply Agreement with Galecto to Evaluate GB1211 + Tecentriq (atezolizumab) in P-IIa Trial for...
November 3, 2021
Biocad Presents Results of BCD-021 (biosimilar, bevacizumab) in P-III Study for the Treatment of NSCLC at ESMO 2021
October 27, 2021
Turning Point and EQRx Collaborate to Evaluate Elzovantinib + Aumolertinib in Patients with EGFR Mutant Met-Amplified Advanced NSC...
October 14, 2021
Merck KGaA and GSK Terminate their ~$4.2B Collaboration Due to Clinical Failures
October 4, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.